Published in Proc Natl Acad Sci U S A on October 03, 2011
Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel) (2012) 1.32
TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc (2012) 1.28
Membrane-active peptides and the clustering of anionic lipids. Biophys J (2012) 1.07
Influenza virus A M2 protein generates negative Gaussian membrane curvature necessary for budding and scission. J Am Chem Soc (2013) 1.04
Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs. ACS Chem Biol (2012) 1.04
Plasmonic nanoprobes: from chemical sensing to medical diagnostics and therapy. Nanoscale (2013) 1.00
Molecular basis for nanoscopic membrane curvature generation from quantum mechanical models and synthetic transporter sequences. J Am Chem Soc (2012) 0.96
A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model. Hum Mol Genet (2011) 0.94
Engineering persister-specific antibiotics with synergistic antimicrobial functions. ACS Nano (2014) 0.93
Arginine in α-defensins: differential effects on bactericidal activity correspond to geometry of membrane curvature generation and peptide-lipid phase behavior. J Biol Chem (2012) 0.89
Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering. Curr Opin Solid State Mater Sci (2013) 0.89
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer. Expert Opin Drug Deliv (2014) 0.85
A critical evaluation of random copolymer mimesis of homogeneous antimicrobial peptides. Macromolecules (2013) 0.84
A common landscape for membrane-active peptides. Protein Sci (2013) 0.83
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure. Mol Ther Nucleic Acids (2012) 0.83
Suppression of TLR signaling by targeting TIR domain-containing proteins. Curr Protein Pept Sci (2012) 0.81
Cell-penetrating peptides split into two groups based on modulation of intracellular calcium concentration. J Biol Chem (2012) 0.81
Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment. Mol Pharm (2014) 0.81
Selective recapitulation of conserved and nonconserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration. J Biol Chem (2013) 0.81
Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7. J Biol Chem (2016) 0.80
Design of aromatic-containing cell-penetrating peptide mimics with structurally modified π electronics. Chemistry (2014) 0.80
Self-assembling amphiphilic peptides. J Pept Sci (2014) 0.80
Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells. PLoS One (2013) 0.79
Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies. Int J Mol Sci (2015) 0.79
Enhanced activity of cyclic transporter sequences driven by phase behavior of peptide-lipid complexes. Soft Matter (2015) 0.79
S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages. PLoS Pathog (2016) 0.79
Interaction between a cationic surfactant-like peptide and lipid vesicles and its relationship to antimicrobial activity. Langmuir (2013) 0.78
Imaging the DNA damage response with PET and SPECT. Eur J Nucl Med Mol Imaging (2017) 0.78
Investigating Hydrophilic Pores in Model Lipid Bilayers Using Molecular Simulations: Correlating Bilayer Properties with Pore-Formation Thermodynamics. Langmuir (2015) 0.77
Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA. Chem Biol (2014) 0.77
Amorphous calcium phosphate nanoparticles could function as a novel cancer therapeutic agent by employing a suitable targeted drug delivery platform. Nanoscale Res Lett (2013) 0.77
Arginine rich short linear motif of HIV-1 regulatory proteins inhibits dicer dependent RNA interference. Retrovirology (2013) 0.77
Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility. Hum Reprod (2013) 0.77
Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods Mol Biol (2015) 0.76
Detergent induction of HEK 293A cell membrane permeability measured under quiescent and superfusion conditions using whole cell patch clamp. J Phys Chem B (2014) 0.76
Spontaneous membrane-translocating peptide adsorption at silica surfaces: a molecular dynamics study. J Phys Chem B (2013) 0.75
Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction. Cell Death Dis (2015) 0.75
Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat. Int J Pept (2012) 0.75
An Intrinsically Disordered Peptide Facilitates Non-Endosomal Cell Entry. Angew Chem Int Ed Engl (2016) 0.75
Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes. J Invest Dermatol (2015) 0.75
Reinventing Cell Penetrating Peptides Using Glycosylated Methionine Sulfonium Ion Sequences. ACS Cent Sci (2015) 0.75
Preparation of cell-permeable Cre recombinase by expressed protein ligation. BMC Biotechnol (2015) 0.75
Antimicrobial Peptides Share a Common Interaction Driven by Membrane Line Tension Reduction. Biophys J (2016) 0.75
Depicting Binding-Mediated Translocation of HIV-1 Tat Peptides in Living Cells with Nanoscale Pens of Tat-Conjugated Quantum Dots. Sensors (Basel) (2017) 0.75
Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations. Arch Pharm Res (2016) 0.75
Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold. Sci Rep (2015) 0.75
Trigger-Responsive Gene Transporters for Anticancer Therapy. Nanomaterials (Basel) (2017) 0.75
Focused Library Approach to Discover Discrete Dipeptide Bolaamphiphiles for siRNA Delivery. Biomacromolecules (2016) 0.75
Glycosaminoglycan Binding and Non-Endocytic Membrane Translocation of Cell-Permeable Octaarginine Monitored by Real-Time In-Cell NMR Spectroscopy. Pharmaceuticals (Basel) (2017) 0.75
Engineering liposomal nanoparticles for targeted gene therapy. Gene Ther (2017) 0.75
Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 7.87
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol (2000) 6.90
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med (2004) 6.48
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem (2002) 6.01
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem (2000) 4.02
An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science (1998) 3.80
Action of antimicrobial peptides: two-state model. Biochemistry (2000) 3.49
Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta (1999) 3.49
Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res (2000) 3.41
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A (2001) 3.06
A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic (2007) 3.01
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem (2000) 2.98
Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther (2004) 2.82
Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release (2005) 2.74
Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev (2005) 2.70
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun (1998) 2.67
Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem (2005) 2.46
Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem (2003) 2.23
Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry (1998) 2.18
Arginine-rich cell-penetrating peptides. FEBS Lett (2009) 2.17
Pathway for polyarginine entry into mammalian cells. Biochemistry (2004) 2.14
Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem (2003) 2.09
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A (2003) 2.05
Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J (2009) 1.99
Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc Natl Acad Sci U S A (2007) 1.98
The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev (2007) 1.91
Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry (2007) 1.83
Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts. Biochem J (2000) 1.59
Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther (2003) 1.52
Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res (2005) 1.49
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding. Angew Chem Int Ed Engl (2008) 1.47
Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev (2005) 1.46
Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. Biochem J (2007) 1.44
Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans. Adv Drug Deliv Rev (2007) 1.43
Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem (2008) 1.41
Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys J (2009) 1.40
Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry (2003) 1.35
Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction. J Biol Chem (2009) 1.31
Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J Biol Chem (2003) 1.30
Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta (2005) 1.27
Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. Nat Mater (2006) 1.24
Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J Am Chem Soc (2002) 1.24
Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. Biochemistry (1992) 1.22
Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug Chem (2004) 1.18
Water-protein interactions of an arginine-rich membrane peptide in lipid bilayers investigated by solid-state nuclear magnetic resonance spectroscopy. J Phys Chem B (2010) 1.17
Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry (2005) 1.12
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem (2007) 1.07
Control of electrostatic interactions between F-actin and genetically modified lysozyme in aqueous media. Proc Natl Acad Sci U S A (2007) 1.07
Dendrimeric molecular transporters: synthesis and evaluation of tunable polyguanidino dendrimers that facilitate cellular uptake. Org Lett (2005) 0.97
Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. Biochemistry (2001) 0.97
Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. Biochim Biophys Acta (2006) 0.97
Stability of inverse bicontinuous cubic phases in lipid-water mixtures Phys Rev Lett (2000) 0.96
First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling. Biol Cell (2007) 0.95
Structure and stability of self-assembled actin-lysozyme complexes in salty water. Phys Rev Lett (2005) 0.93
Polymorphism of DNA-anionic liposome complexes reveals hierarchy of ion-mediated interactions. Proc Natl Acad Sci U S A (2005) 0.90
Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action. J Pept Sci (2009) 0.88
Effective photoinactivation of Gram-positive and Gram-negative bacterial strains using an HIV-1 Tat peptide-porphyrin conjugate. Photochem Photobiol Sci (2010) 0.84
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature (2002) 3.24
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci U S A (2008) 2.41
Stimuli-responsive polypeptide vesicles by conformation-specific assembly. Nat Mater (2004) 2.41
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
Arginine-rich cell-penetrating peptides. FEBS Lett (2009) 2.17
The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog (2011) 2.04
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. Blood (2007) 2.00
Bacteria use type IV pili to walk upright and detach from surfaces. Science (2010) 1.71
Seasonal cholera from multiple small outbreaks, rural Bangladesh. Emerg Infect Dis (2008) 1.70
ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS One (2012) 1.69
Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A (2010) 1.64
Self-assembled virus-membrane complexes. Nat Mater (2004) 1.63
Like-charge attraction between polyelectrolytes induced by counterion charge density waves. Proc Natl Acad Sci U S A (2003) 1.62
Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe (2011) 1.61
Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clin Cancer Res (2006) 1.59
Epidemiological study of Vibrio cholerae using variable number of tandem repeats. FEMS Microbiol Lett (2008) 1.57
Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc Natl Acad Sci U S A (2011) 1.57
In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells. J Control Release (2008) 1.54
Inhibition of transferrin iron release increases in vitro drug carrier efficacy. J Control Release (2006) 1.54
Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angew Chem Int Ed Engl (2009) 1.50
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding. Angew Chem Int Ed Engl (2008) 1.47
Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem (2005) 1.45
Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res (2010) 1.44
Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther (2003) 1.43
Flagella and pili-mediated near-surface single-cell motility mechanisms in P. aeruginosa. Biophys J (2011) 1.43
IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol (2009) 1.42
Structure and dynamics of liquid crystalline pattern formation in drying droplets of DNA. Phys Rev Lett (2006) 1.42
Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Cancer Chemother Pharmacol (2005) 1.41
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. Cancer Biol Ther (2004) 1.40
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood (2008) 1.40
Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials (2005) 1.38
The intracellular trafficking pathway of transferrin. Biochim Biophys Acta (2011) 1.36
Validation data-based adjustments for outcome misclassification in logistic regression: an illustration. Epidemiology (2011) 1.35
Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res (2008) 1.34
Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles. Angew Chem Int Ed Engl (2008) 1.33
Hexamethyldisilazane-mediated controlled polymerization of alpha-amino acid N-carboxyanhydrides. J Am Chem Soc (2007) 1.32
Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes. J Am Chem Soc (2007) 1.29
Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol Sin (2007) 1.27
Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. Nat Mater (2006) 1.24
Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. ACS Nano (2012) 1.23
Bacteria use type-IV pili to slingshot on surfaces. Proc Natl Acad Sci U S A (2011) 1.22
Ionic polypeptides with unusual helical stability. Nat Commun (2011) 1.21
Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery. Angew Chem Int Ed Engl (2011) 1.21
Mechanism of a prototypical synthetic membrane-active antimicrobial: Efficient hole-punching via interaction with negative intrinsic curvature lipids. Proc Natl Acad Sci U S A (2008) 1.20
N-Trimethylsilyl amines for controlled ring-opening polymerization of amino acid N-carboxyanhydrides and facile end group functionalization of polypeptides. J Am Chem Soc (2008) 1.19
Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. J Am Chem Soc (2009) 1.19
Tools to support policy decisions related to treatment strategies and surveillance of Schistosomiasis japonica towards elimination. PLoS Negl Trop Dis (2011) 1.18
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res (2012) 1.18
Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J Immunol (2010) 1.17
Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes. J Control Release (2008) 1.16
Role of mechanical factors in fate decisions of stem cells. Regen Med (2011) 1.15
Nanoscale double emulsions stabilized by single-component block copolypeptides. Nature (2008) 1.15
Structural polymorphism of the actin-espin system: a prototypical system of filaments and linkers in stereocilia. Phys Rev Lett (2007) 1.14
The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials (2010) 1.14
Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis. Obstet Gynecol (2010) 1.14
IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6. J Immunol (2008) 1.12
Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem (2004) 1.10
Rice zinc finger protein DST enhances grain production through controlling Gn1a/OsCKX2 expression. Proc Natl Acad Sci U S A (2013) 1.10
Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia. Blood (2013) 1.09
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates. Bioconjug Chem (2010) 1.08
Charged polypeptide vesicles with controllable diameter. J Am Chem Soc (2005) 1.08
Automated 3-D method for the correction of axial artifacts in spectral-domain optical coherence tomography images. Biomed Opt Express (2011) 1.08
Ion multivalence and like-charge polyelectrolyte attraction. Phys Rev Lett (2003) 1.07
Inhibition of bladder cancer development by allyl isothiocyanate. Carcinogenesis (2009) 1.07
Control of electrostatic interactions between F-actin and genetically modified lysozyme in aqueous media. Proc Natl Acad Sci U S A (2007) 1.07
Protein corona significantly reduces active targeting yield. Chem Commun (Camb) (2013) 1.05
Nonporous Silica Nanoparticles for Nanomedicine Application. Nano Today (2013) 1.04
Automated analysis of retinal images for detection of referable diabetic retinopathy. JAMA Ophthalmol (2013) 1.04
Influenza virus A M2 protein generates negative Gaussian membrane curvature necessary for budding and scission. J Am Chem Soc (2013) 1.04
Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors. Angew Chem Int Ed Engl (2012) 1.03
Elasticity-mediated nematiclike bacterial organization in model extracellular DNA matrix. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 1.03
Likelihood-based methods for regression analysis with binary exposure status assessed by pooling. Stat Med (2012) 1.03
Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol (2012) 1.03
General method for purification of α-amino acid-n-carboxyanhydrides using flash chromatography. Biomacromolecules (2010) 1.03
Synthesis of polypeptides by ring-opening polymerization of α-amino acid N-carboxyanhydrides. Top Curr Chem (2012) 1.03
High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod (2007) 1.02
Temperature dependence of thermodiffusion in aqueous suspensions of charged nanoparticles. Langmuir (2007) 1.02
Structural brain abnormalities in patients with primary open-angle glaucoma: a study with 3T MR imaging. Invest Ophthalmol Vis Sci (2013) 1.01
A cell-penetrating helical polymer for siRNA delivery to mammalian cells. Mol Ther (2012) 1.00
Performance of a dipstick dye immunoassay for rapid screening of Schistosoma japonicum infection in areas of low endemicity. Parasit Vectors (2011) 0.99
[A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy]. Zhonghua Yi Xue Za Zhi (2002) 0.99
Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci (2010) 0.98
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control (2011) 0.98
Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes. Adv Mater (2013) 0.98
Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the central nervous system. Biomaterials (2009) 0.98
Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury. PLoS One (2013) 0.97
Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylation. J Biol Chem (2011) 0.97
Molecular basis for nanoscopic membrane curvature generation from quantum mechanical models and synthetic transporter sequences. J Am Chem Soc (2012) 0.96
Staphylococcus epidermidis Csm1 is a 3'-5' exonuclease. Nucleic Acids Res (2013) 0.96